NAD+ overconsumption by poly (ADP-ribose) polymerase (PARP) under oxidative stress induces cytoskeletal disruption in vascular endothelial cell
Open Access
- 6 July 2024
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 731, 150371
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Nicotinamide mononucleotide (NMN) alleviates the poly(I:C)-induced inflammatory response in human primary cell culturesScientific Reports, 2023
- SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expressionScience Advances, 2022
- Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse modelsCell Discovery, 2022
- Kinase signaling as a drug target modality for regulation of vascular hyperpermeability: A case for ARDS therapy developmentDrug Discovery Today, 2022
- Viral infection as an NAD+ battlefieldNature Metabolism, 2022
- NAD+ metabolism and its roles in cellular processes during ageingNature Reviews Molecular Cell Biology, 2020
- Dynamic Regulation of Vascular Permeability by Vascular Endothelial Cadherin-Mediated Endothelial Cell-Cell JunctionsJournal of Nippon Medical School, 2017
- On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1Genes & Development, 2012
- Role of Poly(ADP‐ribose) polymerase 1 (PARP‐1) in Cardiovascular Diseases: The Therapeutic Potential of PARP InhibitorsCardiovascular Drug Reviews, 2007
- Signaling Mechanisms Regulating Endothelial PermeabilityPhysiological Reviews, 2006